EirGenix Inc. (TPE:6589)
Taiwan · Delayed Price · Currency is TWD 62.20
-1.10 (-1.74%)
At close: Jan 30, 2026
EirGenix Market Cap
EirGenix has a market cap or net worth of 18.82 billion as of January 30, 2026. Its market cap has decreased by -16.95% in one year.
Market Cap
18.82B
Enterprise Value
17.34B
Revenue
936.18M
Ranking
n/a
PE Ratio
n/a
Stock Price
62.20
Market Cap Chart
Since November 23, 2016, EirGenix's market cap has increased from 4.56B to 18.82B, an increase of 312.98%. That is a compound annual growth rate of 16.68%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 30, 2026 | 18.82B | 0.81% |
| Dec 31, 2025 | 18.67B | -15.33% |
| Dec 31, 2024 | 22.05B | -28.29% |
| Dec 29, 2023 | 30.75B | -17.85% |
| Dec 30, 2022 | 37.43B | 11.81% |
| Dec 30, 2021 | 33.48B | 245.12% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Nov 23, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Lin BioScience | 31.68B |
| Oneness Biotech | 31.48B |
| Lumosa Therapeutics | 29.57B |
| Polaris Group | 23.88B |
| Sunmax Biotechnology | 21.10B |
| TaiMed Biologics | 15.46B |
| AP Biosciences | 14.68B |
| Tanvex BioPharma | 13.85B |